Detalhe da pesquisa
1.
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease.
Ann Neurol
; 90(3): E1-E12, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021620
2.
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease.
Ann Neurol
; 88(2): 320-331, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32441370
3.
α-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease.
Mov Disord
; 36(11): 2508-2518, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34002893
4.
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PDGBA.
Mov Disord
; 36(5): 1216-1228, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547828
5.
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s disease.
Eur J Neurol
; 28(5): 1557-1565, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449400
6.
Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism.
Brain
; 143(10): 3041-3051, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029617
7.
CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories.
Mov Disord
; 35(7): 1138-1144, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32445500
8.
Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha-Synuclein Profiles.
Mov Disord
; 35(3): 495-499, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31670439
9.
Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's Disease.
Mov Disord
; 35(7): 1233-1238, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32338403
10.
Parkinson's disease: evolution of cognitive impairment and CSF Aß1-42 profiles in a prospective longitudinal study.
J Neurol Neurosurg Psychiatry
; 90(2): 165-170, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30254084
11.
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile.
Mov Disord
; 34(7): 1069-1073, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189032
12.
Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches.
Clin Chem Lab Med
; 57(10): 1556-1564, 2019 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31251725
13.
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles.
Mov Disord
; 32(12): 1780-1783, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29094781
14.
Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
Neurodegener Dis
; 17(2-3): 83-88, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27760429
15.
Validating Alzheimer's disease micro RNAs using next-generation sequencing.
Alzheimers Dement
; 12(5): 565-76, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26806387
16.
Association of Misfolded α-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson's Disease Diagnosis and Duration.
J Parkinsons Dis
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669557
17.
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers.
NPJ Parkinsons Dis
; 10(1): 88, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649346
18.
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson's disease.
NPJ Parkinsons Dis
; 10(1): 24, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242875
19.
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD.
NPJ Parkinsons Dis
; 9(1): 38, 2023 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906614
20.
Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
Mov Disord
; 27(2): 288-92, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22021190